Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma

Saved in:
Bibliographic Details
Published in:Blood and Lymphatic Cancer : Targets and Therapy
Format: Online Article RSS Article
Published: 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868552785578950657
collection WordPress RSS
FRELIP Feed Integration
container_title Blood and Lymphatic Cancer : Targets and Therapy
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:61065
institution FRELIP
journal_source_facet Blood and Lymphatic Cancer : Targets and Therapy
last_indexed 2026-06-20T21:26:07.255Z
publishDate 2025
publishDateSort 2025
record_format rss_article
spellingShingle Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma
title_alt Ensayo de fase II de una terapia combinada basada en orelabrutinib en linfoma primario del sistema nervioso central recién diagnosticado
Essai de phase II d'une thérapie combinée à base d'orelabrutinib dans le lymphome primitif du système nerveux central nouvellement diagnostiqué
Ensaio de fase II de uma terapia combinada baseada em orelabrutinibe no linfoma primário do sistema nervoso central recém-diagnosticado
title_auth Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma
title_es_txt Ensayo de fase II de una terapia combinada basada en orelabrutinib en linfoma primario del sistema nervioso central recién diagnosticado
title_fr_txt Essai de phase II d'une thérapie combinée à base d'orelabrutinib dans le lymphome primitif du système nerveux central nouvellement diagnostiqué
title_full Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma
title_fullStr Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma
title_full_unstemmed Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma
title_pt_txt Ensaio de fase II de uma terapia combinada baseada em orelabrutinibe no linfoma primário do sistema nervoso central recém-diagnosticado
title_short Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma
title_sort phase ii trial of an orelabrutinib-based combination therapy in newly diagnosed primary central nervous system lymphoma
topic Oncology
General
Oncology
url https://www.dovepress.com/phase-ii-trial-of-an-orelabrutinib-based-combination-therapy-in-newly--peer-reviewed-fulltext-article-BLCTT